Malaria Parasite Overview PDF
Document Details
Uploaded by Deleted User
Tags
Summary
This document provides an overview of the Phylum Apicomplexa, focusing on the genus Plasmodium. It details the different species of Plasmodium that infect humans and cause malaria, outlining their characteristics, life cycles, epidemiology, and diagnosis. The document also discusses prevention strategies, including natural resistance and drug interventions.
Full Transcript
Phylum Apicomplexa Overview: Class Sporozoea ○ Subclass Coccidiasina Order Eucoccidia Suborder Haemosporina: Genus Plasmodium (e.g., species causing malaria) Suborder Eimeriina: Genera Toxoplasma, Cr...
Phylum Apicomplexa Overview: Class Sporozoea ○ Subclass Coccidiasina Order Eucoccidia Suborder Haemosporina: Genus Plasmodium (e.g., species causing malaria) Suborder Eimeriina: Genera Toxoplasma, Cryptosporidium, Isospora (causing toxoplasmosis, cryptosporidiosis, and isosporiasis) Subclass Piroplasmasina Genus Babesia (causes babesiosis, similar to malaria) General Characteristics of Apicomplexa: Morphology: ○ Subpellicular microtubules ○ Apical complex: Contains distinctive organelles: Rhoptries Micronemes Dense granules ○ These structures aid in host cell invasion. Genus Plasmodium: Infects red blood cells in humans. Four Species Infecting Humans: ○ Plasmodium falciparum: Infects all red blood cells (RBCs) – malignant tertian malaria ○ Plasmodium vivax: Infects reticulocytes (young RBCs) – benign tertian malaria ○ Plasmodium ovale: Infects reticulocytes – benign tertian malaria ○ Plasmodium malariae: Infects older RBCs – quartan malaria ○ Plasmodium knowlesi: Has a 24-hour blood stage cycle, historically rare in humans Plasmodium falciparum: Epidemiology: ○ Vector: Female Anopheles mosquitoes (Anopheles gambiae complex, A. funestus, and others) ○ Distribution: Mostly in tropical regions ○ Children and newly exposed individuals are at higher risk. ○ WHO (2023): 247 million malaria cases, 619,000 deaths globally, primarily due to P. falciparum. ○ Mortality Rate: 14.3 deaths per 100,000 population at risk. Plasmodium Life Cycle: ○ Sporozoite: Infective form transmitted by mosquito bite. ○ Merozoite: Free parasites released from infected cells (RBCs). ○ Ring stage: Early trophozoite. ○ Trophozoite: Feeding stage within RBCs. ○ Schizont: Undergoes asexual reproduction, leading to release of merozoites. ○ Gametocytes: Sexual forms that can be taken up by a mosquito to continue the cycle. Clinical Presentation: ○ Pre-patent Period: 10-14 days after the bite. ○ Fever Cycles: Occur every 36 to 72 hours, with characteristic symptoms: Chills, hot stage (high fever, altered consciousness, abdominal pain, diarrhea), sweat stage (fatigue). ○ Complications: Cerebral malaria, renal failure, gastroenteritis, severe anemia, hypoglycemia. Why is P. falciparum more severe?: ○ Infects all types of blood cells. ○ Trophozoite and schizont stages are sequestered in capillaries, evading immune detection. ○ Infected cells express ‘knobs’ (mediated by PfEMP), which adhere to endothelial cells in the brain, kidneys, etc. ○ Antigenic variation allows parasites to evade immune responses. Natural Resistance: ○ Sickle Cell Trait (HbAS): Provides some protection against severe malaria. ○ G6PD Deficiency: Common in Southeast Asia; reduces parasite growth in RBCs. ○ Thalassemias: Reduced production of hemoglobin also offers resistance. Other Plasmodium Species: 1. Plasmodium vivax & Plasmodium ovale: ○ Epidemiology: Wider distribution than P. falciparum (e.g., temperate climates such as Siberia). Resistance in West Africa due to the absence of Duffy antigen, required for invasion by P. vivax. ○ Pathogenesis: Benign tertian malaria: Fevers every 48 hours. Infect reticulocytes (limiting parasitemia to ~1%). Hypnozoites (dormant forms) persist in the liver and can cause relapses. 2. Plasmodium malariae: ○ Pathogenesis: Causes quartan malaria (fevers every 72 hours). Infects older RBCs; less pathogenic and rarely acute. Can remain dormant in the liver for months or years, causing long-term recrudescence. Diagnosis: Blood Smear: Giemsa-stained samples. ○ Thin smear: Detailed observation of morphology. ○ Thick smear: Detection of low levels of parasitemia. Molecular Techniques (PCR): For specific identification of species. Parasite Stages and Intervention Points: Targets for Drug and Immune Therapy: ○ Vector control: Insecticides, larvicides (e.g., DDT). ○ Liver stage drugs: Primaquine. ○ Blood stage drugs: Chloroquine (with increasing resistance), Artemisinin, Doxycycline, Mefloquine. Anopheles Mosquito (Malaria Vector): Various Anopheles species spread malaria, each with different geographical distributions: ○ An. gambiae (Africa), An. albimanus (Central America), An. darlingi (South America), An. stephensi (India), etc. Life Cycle: ○ Females lay eggs on water. ○ Larvae hatch and develop into pupae, which then become adult mosquitoes. ○ Adult female mosquitoes need blood meals to produce eggs.